The emergence of extensively drug-resistant (XDR) typhoid has created a major therapeutic challenge in South Asia. Randomized evidence comparing azithromycin with more intensive antibiotic strategies in uncomplicated enteric fever has helped define when oral therapy remains reasonable and when resistant disease requires escalation. The key clinical issue is not simply selecting an antibiotic but obtaining susceptibility information when feasible, recognizing treatment failure early and understanding local resistance patterns. For physicians in endemic settings, persistent fever, prior antibiotic exposure and epidemiologic context should raise concern for resistant infection. Laboratory confirmation and blood culture remain important whenever possible because empiric use of broad-spectrum agents can accelerate antimicrobial resistance. The management of typhoid also highlights the role of prevention through vaccination, sanitation and safe food and water. The broader message for APICON is that “guidelines versus realities” becomes particularly important in infectious disease: recommendations are only effective when diagnostic capacity, antimicrobial stewardship and local epidemiology are incorporated into clinical decision-making.